Peripheral blood stem cell mobilization with low dose rhG-CSF in 56 unrelated healthy donors.
- Author:
Pei LI
1
;
Guo-Yun ZHANG
;
Pin ZHU
;
Bei-Qian WU
;
Qiang NIU
;
Yi XIE
Author Information
1. Department of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Blood Donors;
Female;
Granulocyte Colony-Stimulating Factor;
administration & dosage;
Hematopoietic Stem Cell Mobilization;
methods;
Humans;
Male;
Middle Aged;
Peripheral Blood Stem Cell Transplantation;
Recombinant Proteins
- From:
Journal of Experimental Hematology
2007;15(2):348-351
- CountryChina
- Language:Chinese
-
Abstract:
The study was aimed to observe the effect of recombinant human granulocyte-colony stimulating factors (rhG-CSF) in low dose on peripheral blood stem cell (PBSC) mobilization in unrelated healthy normal donors. G-CSF was administered at 5 microg/(kg x d) subcutaneously for successive 5 or 6 days to 56 unrelated donors. Stem cells were harvested on the fourth and fifth days or on the fifth and sixth days. The numbers of mononuclear cells (MNC), CD34(+) cells and Hb, Plt, and CD3(+), CD4(+), CD8(+) and CD20(+) cells were determined during the mobilization. The results showed that most common adverse events were bone pain (17.9%, 10/56), agrypnia (8.9%, 5/56) and lassitude (4.5%, 3/56) during rhG-CSF mobilization, but all donors were suffered less than grade II according to the WHO criteria, and did not need to stop the mobilization and not need to give special treatment. In harvest on day 4 - 5 and 5 - 6, MNC count was (5.95 +/- 1.52) x 10(8)/kg and (7.19 +/- 2.12) x 10(8)/kg; CD34(+) cells count was (3.03 +/- 1.09) x 10(6)/kg and (7.92 +/- 2.50) x 10(6)/kg. There were no significant differences in hemoglobin level and platelet count, the percentage of CD3(+) cells, CD4(+) cells, CD8(+) cells and CD20(+) cells between pre-mobilization and post-mobilization of rhG-CSF. It is concluded that the low dose of rhG-CSF 5 microg/(kg x d) for peripheral blood stem cell mobilization in unrelated healthy normal donors is safe and effective.
